Sitemap
Page 1 of 38 : Next Page
Posts
- Category: Adderall
- 'Brain Gain' drugs increasing on college campuses
- Brain Gain: The underground world of neuro-enhancing drugs.
- Essay-enhancing drugs
- Illegal drugs aid concentration
- Is Adderall Good for the Economy?
- Mind-enhancing drugs: A no-brainer?
- Neuro-enhancers: drug of the decade
- Pill wars: should we use drugs to boost our brains?
- Provigil & Ritalin: Brain-Doping at the Lab Bench
- The New Illicit Drugs: Kids Who Don't Need Cognitive Enhancers Take Them Anyway
- Why not use drugs for brainpower?
- Category: Cephalon Stock
- Category: multiple sclerosis
- Category: Narcolepsy
- Fighting to stay awake
- Genetic study confirms the immune system's role in narcolepsy
- Management of Excessive Daytime Sleepiness Reviewed
- Narcolepsy Confirmed as an Auto-Immune Disorder
- Narcolepsy: Understanding the sleep-wake cycle
- Provigil/Modafinil users look to Facebook groups for advice
- Provigil: Using the news to sell drugs online
- Up Close & Personal: Methylphenidate AKA Ritalin
- Category: Nuvigil
- A Pandora's box full of smart drugs
- Adolescent sleep disorders can cause health, money issues - LubbockOnline.com
- Analysts' Weekly Ratings Changes for Cephalon, Inc. (NASDAQ: CEPH) - American Banking News
- Beyond the cliff, dividends, M&A beckon for big pharma - National Post (registration)
- Biotech/Pharma Docket - Patent Docs
- Bipolar Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018 - MarketWatch (press release)
- Bipolar Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018 - PR Newswire (press release)
- Bipolar Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018 - Sacramento Bee
- Bipolar Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018 - Virtual Press Office (press release)
- Business traveller: How to beat jet lag - Financial Times
- Cephalon 1Q profit surges on investment gain - Forbes
- Cephalon aims Nuvigil at depression
- Cephalon Comes Out with Nuvigil, the First Drug for Jet Lag
- Cephalon Drops Nuvigil Patent Suit Against Teva - Law360 (subscription)
- Cephalon highlights positive data from large-scale Nuvigil trial - Zenopa
- Cephalon Nuvigil tablets show positive results in Phase IV trial - Pharmaceutical Business Review
- Cephalon opposes Valeant Pharma's board nominees - BusinessWeek
- Cephalon Presents Positive Results with Nuvigil - Sleep Review
- Cephalon Presents Positive Results with NUVIGIL in Largest Shift Work Disorder ... - Bradenton Herald
- Cephalon shares jump after Nuvigil study data
- Cephalon's potential blockbusters: an overview - Bizjournals.com (blog)
- Court log, July 21, 22, 26 - The Keene Sentinel
- Deals of the Week Is Not Ripe for Restructuring - The IN VIVO Blog (blog)
- District Court Report - Martha's Vineyard Times
Plugin by dagondesign.com